Zuyderland Medisch Centrum Stichting

Cardiology and Acute Coronary Syndrome

Clinical research in cardiology is centred on patients with acute coronary syndrome who require percutaneous coronary intervention and ongoing anticoagulant and antiplatelet treatment.

  • Dual antithrombotic therapy
  • Non-vitamin K oral anticoagulants
  • Post-PCI management

The cardiovascular programme also includes real-world registry work focused on treatment selection in patients with overlapping thrombotic and bleeding risk.

Bariatric Surgery and Obesity Surgery

Research activity in bariatric surgery addresses outcomes after Roux-en-Y gastric bypass and gastric sleeve surgery, with attention to weight regain and variable response after operative treatment for obesity.

  • Weight regain after surgery
  • Postoperative obesity management
  • Metabolic surgery outcomes

These studies reflect an interest in longer-term control of body weight following surgical treatment.

Medical Obesity Treatment

Additional research focuses on pharmacological management of obesity in patients with limited weight loss after surgery, including treatment strategies that combine medication with lifestyle intervention.

  • Semaglutide
  • Naltrexone/bupropion
  • Weight loss maintenance

The therapeutic emphasis is on improving total weight loss in post-surgical patients who remain at risk of persistent excess weight.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Semaglutide for Weight Loss in Obesity Patients with Low Response After Bariatric Surgery

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Bupropion Hydrochloride and Naltrexone Hydrochloride for Patients with Weight Regain After Bariatric Surgery

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands
  • Study Comparing Dabigatran with Ticagrelor or Clopidogrel for Patients with Acute Coronary Syndrome Undergoing PCI

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands